Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Genes Chromosomes Cancer. 2011 May 16;50(8):644–653. doi: 10.1002/gcc.20886

Table 1.

Clinical, pathologic, and Molecular Findings in Epithelioid Hemangioendothelioma.

EHE Case # Age Sex Location Malig Grade FISH rearrangements for WWTR1 & CAMTA1 Clinical Follow-Up (mo)
1 68 M ST, arm yes +* NED (16)
2 59 F ST, groin no + NED (116)
3 39 M ST, subclavicle yes + NED (14)
4 54 M ST, arm yes +* NED (108)
5 52 F ST, abd wall, bilateral breast yes + AWD (15)
6 66 M ST, neck/shoulder no +* NED (4)
7 39 F ST, axilla no + DOD (43)
8 42 F IT, mediastinum, lung, SVC yes + NED (23)
9 34 M IT, lung, pleura yes + DOD (4)
10 32 M IT, pleura yes + AWD (7)
11 29 F IT, lung, paratracheal LNs yes + LFU
12 61 M IT, lung no + DOD (82)
13 65 F IT, lung no + NED (20)
14 55 M IT, lung no + NED (30)
15 41 F Liver no + NED (7)
16 48 F Liver no + LFU
17 25 M Bone/mandible yes + DOD (24)

EHE, epithelioid hemangioendothelioma, ST, soft tissue, IT, intra-thoracic, Malig, malignant,

*

RT-PCR confirmation of WWTR1-CAMTA1 fusion product, mo, months, NED, no evidence of disease, AWD, alive with disease, DOD, died of disease, LFU, lost follow-up.

HHS Vulnerability Disclosure